Commercial Lines
Japanese M&A Wave to Continue in U.S. Insurance Market: Bankers
Japanese insurers made more than $18 billion worth of acquisitions in the U.S. last year, and their spending spree isn't over yet, industry dealmakers said on Tuesday. Japan has a number of large, ...
U.S. Mortage Insurance Brightens an Uneven 2016 Global Market: S&P
Mortgage insurers in the U.S. are set for a robust 2016, a bright spot in an otherwise uneven global market, where success will depend on the region of the world in which carriers are doing business, ...
MAPFRE Promotes CEO Credited with Greatly Expanding U.S. Operations
MAPFRE S.A. made two big changes to its global executive roster, with one executive in particular gaining a greater role after successfully growing the insurer's U.S. operations. The Spanish ...
U.S. Insured Losses Hit $3.8B in Q1; Worst in a Decade: PCS/Verisk
Catastrophe activity in the U.S. led to $3.8 billion in insured losses in 29 states during the 2016 first quarter, with much of the damage hitting Texas. Those events were the worst in a decade in ...
Commercial Drone Insurance Coverage Coming from Willis Towers Watson Arm
Willis Towers Watson will team with a commercial drone trade association to offer coverage for the sector designed for both owners and operators of the technology. Dubbed DroneGuard, the insurance ...
The Latest Launches From Chubb, Beazley and Willis Towers Watson
Beazley is rolling out new specialist medical professional liability coverage for small healthcare providers. Willis Towers Watson debuted a new plan option for companies that operate in and service ...
Inside Travelers’ New Predictive Model: Targeting Chronic Pain, Opioid Use
In response to rising chronic pain claims, Travelers announced the development of a new patent-pending predictive model designed to identify claims and workers most at risk. The company, which ...
1,000 Talc-Cancer Suits Head J&J’s Way After $55M Verdict Loss
Johnson & Johnson must pay $55 million to a 62-year-old South Dakota woman who blamed her ovarian cancer on the company's talcum powder in the second such trial loss this year. J&J is accused ...